柏勒罗丰治疗

BLPH NASDAQ
0.6201
-0.0139
-2.19%
已收盘, 16:00 06/14 EDT
开盘
0.6310
昨收
0.6340
最高
0.6500
最低
0.6000
成交量
13.50万
成交均量(3M)
26.05万
52周最高
3.300
52周最低
0.4700
换手率
0.20%
市值
4,272.91万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供柏勒罗丰治疗 BLPH股票价格,柏勒罗丰治疗股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary hypertension (PH), using its delivery system, INOpulse, with pulmonary arterial hypertension (PAH) as the lead indication. Its INOpulse device has a mechanism that delivers brief, targeted pulses of nitric oxide timed to occur at the beginning of a breath for delivery to the alveoli of the lungs, which minimizes the amount of drug required for treatment. The Company's second program, BCM, is a medical device focused to prevent congestive heart failure following a ST Segment Elevation Myocardial Infarction (STEMI), which is a type of severe heart attack. The Company's BCM is in PRESERVATION I clinical trial.
展开 >

最近浏览

名称
价格
涨跌幅